Insights That

Move You Forward

Helping you make smarter decisions, avoid costly missteps, and
bring safe, effective products to market with confidence

Large vs. Boutique CRO: Which Is Right For Your Clinical Trial?
Clinical Research, Regulatory Strategy, CRO Services, Medical Device Development Crystal Norwood Clinical Research, Regulatory Strategy, CRO Services, Medical Device Development Crystal Norwood

Large vs. Boutique CRO: Which Is Right For Your Clinical Trial?

Choosing between a large CRO and a boutique CRO can significantly impact clinical trial timelines, budgets, and outcomes. This article explores the strengths and limitations of each model, outlines key questions sponsors should ask during vendor selection, and explains why many medical device and combination product companies benefit from a more specialized, hands-on CRO partnership.

Read More
The FDA’s QMSR Is Now in Effect
Regulatory Strategy, Quality Systems, FDA Compliance, Risk Management, Medical Device Development Crystal Norwood Regulatory Strategy, Quality Systems, FDA Compliance, Risk Management, Medical Device Development Crystal Norwood

The FDA’s QMSR Is Now in Effect

The FDA’s Quality Management System Regulation (QMSR) is now in effect, aligning U.S. medical device quality requirements with ISO 13485. Learn what’s changed, how FDA inspections are evolving, and how manufacturers can implement defensible risk management approaches—without being locked into ISO 14971.

Read More
CRO vs. Consulting Firm: What’s the Difference and Why It Matters
Clinical Research, Regulatory Strategy, Medical Device Development, CRO Services, Consulting & Advisory Crystal Norwood Clinical Research, Regulatory Strategy, Medical Device Development, CRO Services, Consulting & Advisory Crystal Norwood

CRO vs. Consulting Firm: What’s the Difference and Why It Matters

Success in clinical development depends on knowing when to engage a CRO and when to rely on a consulting firm. CROs excel at executing trials with precision, while consulting firms guide strategy, submissions, and compliance. Understanding the difference—and when you need both—can mean the difference between costly delays and streamlined market approval.

Read More